(NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Arthur Levin, PhD, to the Company’s Strategic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback